Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 |
filingDate |
2022-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a408b84398fbad6b11957790a59af49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad34ba50959e75adad14f6187b4070a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb328f0761c109d5c54a675dcf576741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5892451b9a7a79ded653c72cea7949cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48e0eb4a3286997082378a5d7a9b8076 |
publicationDate |
2022-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022234867-A1 |
titleOfInvention |
Sulfonamide having mmp 7-inhibiting action |
abstract |
The present invention provides a compound represented by formula [I] having an MMP 7-inhibiting action or a pharmaceutically acceptable salt thereof. |
priorityDate |
2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |